Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGM - Nasdaq Real Time Price USD

AtriCure, Inc. (ATRC)

Compare
31.83
-2.54
(-7.39%)
At close: March 28 at 4:00:01 PM EDT
31.83
0.00
(0.00%)
After hours: March 28 at 5:31:58 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 124.28M
Earnings -15.57M

Q1'24

Q2'24

Q3'24

Q4'24

0
50M
100M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

45.00
52.22 Average
31.83 Current
60.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 8888
Avg. Estimate -0.22-0.15-0.58-0.4
Low Estimate -0.27-0.17-0.61-0.48
High Estimate -0.15-0.13-0.49-0.26
Year Ago EPS -0.25-0.17-0.67-0.58

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 9999
Avg. Estimate 122.92M130.6M522.85M588.56M
Low Estimate 121.14M129.1M520.6M575M
High Estimate 124.7M131.82M527.72M608.78M
Year Ago Sales 108.85M116.27M465.31M522.85M
Sales Growth (year/est) 12.92%12.32%12.37%12.57%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -0.23-0.17-0.2-0.15
EPS Actual -0.25-0.17-0.17-0.08
Difference -0.0200.030.07
Surprise % -8.30%0.23%13.44%46.22%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.22-0.15-0.58-0.4
7 Days Ago -0.22-0.15-0.58-0.35
30 Days Ago -0.22-0.15-0.58-0.35
60 Days Ago -0.21-0.15-0.62-0.43
90 Days Ago -0.21-0.16-0.64-0.44

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 3352
Up Last 30 Days 3462
Down Last 7 Days 4433
Down Last 30 Days 4323

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ATRC 10.66%9.35%13.59%31.65%
S&P 500 16.20%6.69%10.00%14.33%

Upgrades & Downgrades

Maintains Canaccord Genuity: Buy to Buy 3/28/2025
Maintains JP Morgan: Overweight to Overweight 3/27/2025
Reiterates Needham: Buy to Buy 3/27/2025
Reiterates Needham: Buy to Buy 3/21/2025
Maintains Oppenheimer: Outperform to Outperform 2/13/2025
Maintains Piper Sandler: Overweight to Overweight 2/13/2025

Related Tickers